Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ICU Medical, Inc. - Common Stock (NQ:ICUI)

123.83 +2.88 (+2.39%)
Streaming Delayed Price Updated: 3:17 PM EDT, Aug 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about ICU Medical, Inc. - Common Stock

< Previous 1 2 3 4 Next >
This Parker-Hannifin Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
 
Via Benzinga
3 Small-Cap Stocks That Fall Short
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside... 
Via StockStory
Thermo Fisher, ICU Medical, CONMED, Pediatrix Medical Group, and IQVIA Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. The latest Consumer Price Index (CPI) report showed... 
Via StockStory
Topics Bonds Economy Government
Earnings Scheduled For August 7, 2025
 
Via Benzinga
Earnings Scheduled For May 8, 2025
 
Via Benzinga
Earnings Scheduled For February 27, 2025
 
Via Benzinga
ICUI Q2 Deep Dive: Tariffs Offset Margin Gains Despite Consumables and Systems Progress
Medical device company ICU Medical (NASDAQ:ICUI) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, but sales fell by 8.9% year on year to $543.6 million. Its GAAP profit of $1.43 per... 
Via StockStory
Topics World Trade
ICU Medical (ICUI) Stock Trades Down, Here Is Why
Shares of medical device company ICU Medical (NASDAQ:ICUI) fell 10.5% in the morning session after the company reported second-quarter results where a significant earnings beat was overshadowed by a... 
Via StockStory
Topics ETFs Earnings Stocks
ICU Medical’s (NASDAQ:ICUI) Q2: Beats On Revenue
Medical device company ICU Medical (NASDAQ:ICUI) reported Q2 CY2025 results exceeding the market’s revenue expectations, but sales fell by 8% year on year to $548.9 million. Its GAAP profit of $1.43... 
Via StockStory
ICU Medical (ICUI) Q2 EPS Jumps 40%
Via The Motley Fool
Topics Economy World Trade
ICU Medical (ICUI) Reports Q2: Everything You Need To Know Ahead Of Earnings
Medical device company ICU Medical (NASDAQ:ICUI) will be announcing earnings results this Thursday after market close. Here’s what to expect. 
Via StockStory
Topics Artificial Intelligence World Trade
3 Low-Volatility Stocks That Fall Short
Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets. 
Via StockStory
Lantheus, ICU Medical, Haemonetics, CONMED, and Astrana Health Shares Plummet, What You Need To Know
A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. 
Via StockStory
Topics ETFs Stocks World Trade
ICU Medical (NASDAQ:ICUI): Strongest Q1 Results from the Medical Devices & Supplies - Cardiology, Neurology, Vascular Group
Looking back on medical devices & supplies - cardiology, neurology, vascular stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including ICU Medical (NASDAQ:ICUI) and its... 
Via StockStory
3 Profitable Stocks in Hot Water
A company with profits isn’t always a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential. 
Via StockStory
Solventum, Envista, ICU Medical, Globus Medical, and Enovis Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5%) in response to the positive outcome of U.S.-China trade negotiations, as both sides... 
Via StockStory
Topics Government Stocks World Trade
ICUI Q1 Earnings Call: Product Upgrades and Tariff Headwinds Shape Outlook
Medical device company ICU Medical (NASDAQ:ICUI) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 5.8% year on year to $599.5 million. Its non-GAAP profit of $1.72... 
Via StockStory
Topics World Trade
1 Small-Cap Stock to Target This Week and 2 to Keep Off Your Radar
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a... 
Via StockStory
ICU Medical (NASDAQ:ICUI) Delivers Impressive Q1
Medical device company ICU Medical (NASDAQ:ICUI) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 6.7% year on year to $604.7 million. Its non-GAAP profit of $1.72... 
Via StockStory
What To Expect From ICU Medical’s (ICUI) Q1 Earnings
Medical device company ICU Medical (NASDAQ:ICUI) will be announcing earnings results tomorrow after the bell. Here’s what you need to know. 
Via StockStory
Topics Artificial Intelligence
3 of Wall Street’s Favorite Stocks with Mounting Challenges
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,... 
Via StockStory
Reflecting On Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks’ Q4 Earnings: Merit Medical Systems (NASDAQ:MMSI)
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Merit Medical Systems... 
Via StockStory
Unpacking Q4 Earnings: Artivion (NYSE:AORT) In The Context Of Other Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - cardiology, neurology, vascular industry, including Artivion (NYSE:AORT) and... 
Via StockStory
Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q4 Earnings: ICU Medical (NASDAQ:ICUI) Best of the Bunch
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the medical devices & supplies - cardiology, neurology, vascular stocks, including ICU Medical (NASDAQ:ICUI) and its peers. 
Via StockStory
3 Small-Cap Stocks Skating on Thin Ice
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside... 
Via StockStory
ICU Medical (NASDAQ:ICUI) Surprises With Q4 Sales
Medical device company ICU Medical (NASDAQ:ICUI) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 7.1% year on year to $629.8 million. Its non-GAAP profit of $2.11... 
Via StockStory
ICU Medical (ICUI) Q4 Earnings Report Preview: What To Look For
Medical device company ICU Medical (NASDAQ:ICUI) will be reporting results tomorrow after market close. Here’s what you need to know. 
Via StockStory
Artivion (NYSE:AORT) Q3 Earnings: Leading The Medical Devices & Supplies - Cardiology, Neurology, Vascular Pack
Wrapping up Q3 earnings, we look at the numbers and key takeaways for the medical devices & supplies - cardiology, neurology, vascular stocks, including Artivion (NYSE:AORT) and its peers. 
Via StockStory
Unpacking Q3 Earnings: ICU Medical (NASDAQ:ICUI) In The Context Of Other Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks
As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the medical devices & supplies - cardiology, neurology, vascular industry, including... 
Via StockStory
Spotting Winners: Penumbra (NYSE:PEN) And Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks In Q3
Looking back on medical devices & supplies - cardiology, neurology, vascular stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Penumbra (NYSE:PEN) and its peers. 
Via StockStory
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.